ES2061787T3 - Combinacion de inhibidores de la enzima de conversion de la angiotensina con moduladores del canal del potasio, asi como su empleo en medicamentos. - Google Patents

Combinacion de inhibidores de la enzima de conversion de la angiotensina con moduladores del canal del potasio, asi como su empleo en medicamentos.

Info

Publication number
ES2061787T3
ES2061787T3 ES89109209T ES89109209T ES2061787T3 ES 2061787 T3 ES2061787 T3 ES 2061787T3 ES 89109209 T ES89109209 T ES 89109209T ES 89109209 T ES89109209 T ES 89109209T ES 2061787 T3 ES2061787 T3 ES 2061787T3
Authority
ES
Spain
Prior art keywords
potassium channel
enzyme inhibitors
medicines
combination
well
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89109209T
Other languages
English (en)
Inventor
Reinhard Dr Becker
Rainer Dr Henning
Hansjorg Dr Urbach
Volker Dr Teetz
Heinrich Christian Dr Englert
Dieter Dr Mania
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2061787T3 publication Critical patent/ES2061787T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • H—ELECTRICITY
    • H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02K—DYNAMO-ELECTRIC MACHINES
    • H02K29/00—Motors or generators having non-mechanical commutating devices, e.g. discharge tubes or semiconductor devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Power Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA PATENTE AFECTA A COMBINACIONES DE INHIBIDORES DE ENZIMAS ANGIOTENSIN - CONVERTING CON MODULADORES DE CANAL DE POTASIO, A PROCESOS PARA SU OBTENCION Y A SU USO COMO MEDICAMENTO.
ES89109209T 1988-05-28 1989-05-23 Combinacion de inhibidores de la enzima de conversion de la angiotensina con moduladores del canal del potasio, asi como su empleo en medicamentos. Expired - Lifetime ES2061787T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3818245A DE3818245A1 (de) 1988-05-28 1988-05-28 Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
ES2061787T3 true ES2061787T3 (es) 1994-12-16

Family

ID=6355378

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89109209T Expired - Lifetime ES2061787T3 (es) 1988-05-28 1989-05-23 Combinacion de inhibidores de la enzima de conversion de la angiotensina con moduladores del canal del potasio, asi como su empleo en medicamentos.

Country Status (18)

Country Link
US (1) US4975453A (es)
EP (1) EP0344572B1 (es)
JP (1) JPH0219326A (es)
KR (1) KR900018139A (es)
AT (1) ATE98130T1 (es)
AU (1) AU623397B2 (es)
CA (1) CA1332350C (es)
DE (2) DE3818245A1 (es)
DK (1) DK258889A (es)
ES (1) ES2061787T3 (es)
HU (1) HU205714B (es)
IE (1) IE63328B1 (es)
IL (1) IL90414A (es)
NO (1) NO180773C (es)
NZ (1) NZ229311A (es)
PH (1) PH26420A (es)
PT (1) PT90661B (es)
ZA (1) ZA894013B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2684553B1 (fr) * 1991-12-10 1995-04-07 Bioprojet Soc Civ Nouveaux medicaments pour le traitement de l'hypertension arterielle, de l'insuffisance cardiaque chronique, de l'insuffisance renale et, de maniere generale, d'affections entrainant une retention hydrosodee.
TW244350B (es) * 1991-12-14 1995-04-01 Hoechst Ag
US6083986A (en) * 1996-07-26 2000-07-04 Icagen, Inc. Potassium channel inhibitors
US6333337B1 (en) 1998-01-27 2001-12-25 Icagen, Inc. Potassium channel inhibitors
SE9903028D0 (sv) * 1999-08-27 1999-08-27 Astra Ab New use
CA2382549C (en) * 1999-08-30 2005-03-15 Aventis Pharma Deutschland Gmbh Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
US6458794B2 (en) 1999-12-21 2002-10-01 Icagen, Inc. Potassium channel inhibitors
US6566380B2 (en) 2000-07-25 2003-05-20 Icagen, Inc. Potassium channel inhibitors
US6620849B2 (en) 2000-07-26 2003-09-16 Icafen, Inc. Potassium channel inhibitors
US6849634B2 (en) 2000-12-21 2005-02-01 Icagen Potassium channel inhibitors
KR100591857B1 (ko) * 2004-06-04 2006-06-23 한국유나이티드제약 주식회사 안정성이 개선된 라미프릴 함유 약제학적 조성물
CA2586547A1 (en) * 2004-11-05 2006-05-11 King Pharmaceuticals Research & Development, Inc. Stabilized individually coated ramipril particles, compositions and methods

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3274350D1 (en) * 1981-09-25 1987-01-08 Beecham Group Plc Pharmaceutically active benzopyran compounds
EP0107423B1 (en) * 1982-10-19 1986-07-23 Beecham Group Plc Novel chromans and chromenes
GB8308064D0 (en) * 1983-03-24 1983-05-05 Beecham Group Plc Active compounds
GB8308062D0 (en) * 1983-03-24 1983-05-05 Beecham Group Plc Active compounds
DE3410732A1 (de) * 1984-03-23 1985-09-26 Hoechst Ag, 6230 Frankfurt Methode zur behandlung des glaukoms
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
DE3536687A1 (de) * 1985-10-15 1987-04-16 Hoechst Ag Verfahren zur behandlung von atherosklerose, thrombose und der peripheren gefaesskrankheit
DE3627613A1 (de) * 1986-08-14 1988-02-18 Merck Patent Gmbh Pharmazeutische zubereitung
DE3629060A1 (de) * 1986-08-27 1988-03-03 Bayer Ag Kombination von positiv inotrop wirkenden dihydropyridinen mit ace-hemmern, sowie ihre verwendung in arzneimitteln
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
HU199681B (en) * 1986-11-03 1990-03-28 Sandoz Ag Process for producing new pharmaceutical composition against hypertension and atonic cardiac decomposition
ES2055709T3 (es) * 1986-12-06 1994-09-01 Beecham Group Plc Un procedimiento para preparar una composicion farmaceutica.

Also Published As

Publication number Publication date
ATE98130T1 (de) 1993-12-15
NO892125D0 (no) 1989-05-26
PT90661B (pt) 1994-10-31
AU623397B2 (en) 1992-05-14
US4975453A (en) 1990-12-04
AU3522089A (en) 1989-11-30
EP0344572A2 (de) 1989-12-06
IL90414A (en) 1993-07-08
NO892125L (no) 1989-11-29
IL90414A0 (en) 1990-01-18
PT90661A (pt) 1989-11-30
DK258889D0 (da) 1989-05-26
DK258889A (da) 1989-11-29
NZ229311A (en) 1992-05-26
CA1332350C (en) 1994-10-11
KR900018139A (ko) 1990-12-20
PH26420A (en) 1992-07-15
HUT52370A (en) 1990-07-28
JPH0219326A (ja) 1990-01-23
ZA894013B (en) 1990-02-28
NO180773C (no) 1997-06-18
EP0344572B1 (de) 1993-12-08
HU205714B (en) 1992-06-29
IE891770L (en) 1989-11-28
DE58906338D1 (de) 1994-01-20
NO180773B (no) 1997-03-10
EP0344572A3 (de) 1991-01-16
DE3818245A1 (de) 1989-12-07
IE63328B1 (en) 1995-04-19

Similar Documents

Publication Publication Date Title
ES2138271T3 (es) Compuestos de 6-dimetil-amino-metil-1-fenil-ciclohexano como principio activo farmaceutico.
ES2061787T3 (es) Combinacion de inhibidores de la enzima de conversion de la angiotensina con moduladores del canal del potasio, asi como su empleo en medicamentos.
BR9910251A (pt) Estimulação hematopoiética
ES2196082T3 (es) Analagos del factor de crecimiento de queratinocitos.
IL135068A0 (en) Stimulation of hematopoietic cells in vitro
ES2099056T3 (es) Cepas de lactobacillus de origen humano, sus composiciones y usos de las mismas.
ES2042776T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica.
IT7823092A0 (it) Corpo di carbonio in forma di una placca, e procedimento per la sua fabbricazione.
ES2196172T3 (es) Transplante neuronal utilizando celulas neuroepiteliales pluripotentes.
ES2080037T3 (es) Medicamento de uso topico con actividad cicatrizante.
TR200503846T2 (tr) Değiştirilmiş salimli ensülin sensitizörü için fterkip ve kullanımı
AR004093A1 (es) El uso de una proteina derivada de una quimioquina de mamifero y un medicamento util para movilizar celulas tronco hematopoyeticas.
ZA955788B (en) Dioxo-thiopyrano-pyridine-carboxylic acid derivatives
DE3583588D1 (de) Vulkanisationsbeschleuniger, mittel zum beschleunigen der vulkanisation und den genannten beschleuniger enthaltender kautschukartikel.
ES2183890T3 (es) Uso del factor de crecimiento de hepatocitos para in estimular la proliferacion y diferenciacion de celulas hematopoyeticas.
DK1237537T3 (da) Præparat i form af en gel til modtagelse af et aktivt stof i oplösning eller suspension, især til anvendelse på en slimhinde, og fremgangsmåde til dets fremstilling
AR019499A1 (es) FORMULACIONES ANTIPARÁSITOS Y USO EN LA FABRICACIoN DE MEDICAMENTOS
ES2175153T3 (es) Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia.
AU580890B2 (en) P-acylaminobenzamides
NO970185L (no) Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi
DE3685177D1 (de) Pharmazeutische zubereitung zur behandlung des bluthochdrucks.
ES2183205T3 (es) Hcg y derivados en calidad de inhibidores de melaloproteasas de la matriz.
ES2057528T3 (es) Pdgf-a, pdgf-aa, pdgf-ab, procedimientos de preparacion y medicamentos que los contienen.
NO981320L (no) Oral anvendelse av (+)-O-demetyltramadol som smertemiddel
ECSP951481A (es) Compuestos de 1-fenil-3- dimetilamino propano con efecto farmacologico

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 344572

Country of ref document: ES